Project Grant DP2MD019356
Award Date
9/1/23
Completion Date
6/30/26
Dollars Obligated
$1.4M
Funding Federal Agency
Office of the Director
Awarding Federal Agency
National Institute for Minority Health and Health Disparities
Awardee
Purdue University (YRXVL4JYCEF5)
Federal Grant Program
93.310
Assistance Type
Project Grant
Place of Performance
Indiana, USA
Similar Awards
This Project Grant award from the National Cancer Institute (CFDA 93.396 Cancer Biology Research) provides $630,506 to The Johns Hopkins University to develop novel therapeutic cancer vaccines targeting human papillomavirus (HPV) for the treatment of cervical cancer. The primary goal is to employ spontaneous HPV cervicovaginal carcinoma models to characterize immune evasion mechanisms of HPV E6/E7 variants and evaluate the efficacy of a DNA vaccine against different HPV16 variants. The...
This Project Grant award from the National Cancer Institute (CFDA 93.393 - Cancer Cause and Prevention Research) aims to develop and evaluate an intervention to improve cervical cancer screening and follow-up rates in three diverse, underserved populations: urban inner city Blacks/Haitians (Boston), Hispanic immigrants (Florida), and Hawaiian Natives/Pacific Islanders (Hawaii). The $753,446 award will be used to adapt a successful HPV vaccination intervention for cervical cancer screening,...
This Cooperative Agreement award from the National Cancer Institute (NCI) under the Cancer Cause and Prevention Research program (CFDA 93.393) will fund a hybrid type III effectiveness-implementation trial to test best practices for deploying a "screen and treat" approach to cervical cancer screening utilizing self-collected HPV DNA testing within HIV care and treatment facilities in Mozambique. The 5-year, $643,363 project aims to improve access to affordable HPV testing and promote...
The National Cancer Institute (NCI) awarded a $191,700 Project Grant under the Cancer Research Manpower (CFDA 93.398) program to Northwestern University. The 5-year grant, which began on January 15, 2025, will support a pilot trial to assess the feasibility, acceptability, and effects of four digital intervention components (expert video, self-persuasion, narrative storytelling, and motivational interviewing) aimed at increasing HPV vaccination rates among the U.S. Vietnamese population. The...
This federal Project Grant award of $368,070.00 from the National Cancer Institute (NCI), under the CFDA 93.393 Cancer Cause and Prevention Research program, supports research to identify and address barriers in the cervical cancer treatment cascade among women with HIV in South Africa. The primary awardee, Trustees of Boston University, will conduct qualitative interviews and a pilot randomized controlled trial to develop a multi-level retention care intervention tailored to the unique needs of...
The National Cancer Institute (NCI) awarded a $171,989 Project Grant under the Cancer Research Manpower (CFDA 93.398) program to the University of Florida. The goal of this 5-year grant, with a start date of September 1, 2024, is to adapt an evidence-based intervention called "PINPOINT" to improve cervical cancer screening and care outcomes among women with chronic conditions like obesity and type 2 diabetes, as well as social vulnerabilities such as poverty and rural residence. The...
This Project Grant award, valued at $176,534, was provided by the National Cancer Institute (NCI) under the Cancer Research Manpower (CFDA 93.398) federal grant program. The award will fund research conducted by Oregon Health & Science University (OHSU) to (1) describe cervical cancer screening rates among middle to older age Mexican immigrants at a network of community health centers (CHCs) from 2012-2023, (2) examine individual, organizational, and structural facilitators and barriers to...
This $184,528 federal Project Grant award from the National Cancer Institute (CFDA 93.393 - Cancer Cause and Prevention Research) supports research to define the associations between antibody-bound and unbound vaginal bacterial populations and their functions in women with or without human papillomavirus (HPV) infection and different stages of cervical pathology. The grantee, Case Western Reserve University, will utilize an existing observational cohort to sort vaginal bacterial cells into...
The National Cancer Institute (NCI) awarded a $511,959 Cooperative Agreement under the Cancer Cause and Prevention Research program (CFDA 93.393) to Baylor University. The award supports a hybrid effectiveness-implementation trial evaluating the impact of an evidence-based, home-based self-sampling and behavioral intervention to increase cervical cancer screening among women living with HIV in Ghana. The 5-year project aims to develop culturally appropriate implementation strategies, assess...
The National Cancer Institute (NCI) has awarded a $1,837,497 Cooperative Agreement under the Cancer Cause and Prevention Research (CFDA 93.393) program to New York University (NYU) for the KUPEWA project. The project aims to identify optimal implementation strategies for increasing clinician recommendation of HPV vaccination for girls and young women aged 9-24 living with HIV in Malawi. NYU is collaborating with the University of California, Los Angeles (UCLA) and the Malawi-based Partners In...